Stay updated with breaking news from Nasdaq Tcon. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
TRACON Pharmaceuticals, Inc. (NASDAQ:TCON – Get Free Report) was the recipient of a significant increase in short interest during the month of July. As of July 31st, there was short interest totalling 348,700 shares, an increase of 37.9% from the July 15th total of 252,800 shares. Based on an average trading volume of 356,700 shares, […]
StockNews.com initiated coverage on shares of TRACON Pharmaceuticals (NASDAQ:TCON – Free Report) in a research note published on Friday. The brokerage issued a hold rating on the biopharmaceutical company’s stock. TCON has been the topic of a number of other reports. Maxim Group reduced their target price on shares of TRACON Pharmaceuticals from $8.00 to […]
StockNews.com started coverage on shares of TRACON Pharmaceuticals (NASDAQ:TCON – Free Report) in a research report released on Thursday. The firm issued a hold rating on the biopharmaceutical company’s stock. A number of other brokerages also recently commented on TCON. Robert W. Baird lowered their price objective on TRACON Pharmaceuticals from $8.00 to $7.00 in […]
StockNews.com started coverage on shares of TRACON Pharmaceuticals (NASDAQ:TCON – Free Report) in a research note released on Thursday. The brokerage issued a hold rating on the biopharmaceutical company’s stock. A number of other analysts have also weighed in on TCON. Maxim Group lowered their target price on shares of TRACON Pharmaceuticals from $8.00 to […]
StockNews.com initiated coverage on shares of TRACON Pharmaceuticals (NASDAQ:TCON – Free Report) in a report issued on Wednesday morning. The firm issued a hold rating on the biopharmaceutical company’s stock. Other analysts also recently issued research reports about the stock. Maxim Group reduced their price target on shares of TRACON Pharmaceuticals from $8.00 to $3.00 […]